| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/27/1985 | EP0135429A1 The synthesis of cyclopropane amino acids and peptides |
| 03/27/1985 | EP0135379A2 Basic hexa- and hepta-peptide vasopressin antagonists |
| 03/27/1985 | EP0135352A2 Reagent for use in detecting antibody to human T-cell leukaemia virus antigen |
| 03/27/1985 | EP0135347A1 Human renin and cDNA encoding therefor |
| 03/27/1985 | EP0135291A1 A modified antibiotic resistance gene |
| 03/27/1985 | EP0135277A1 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 03/27/1985 | EP0135182A2 Process for the production of N-alkylated dipeptides and of their esters |
| 03/27/1985 | EP0135181A2 Process for the production of N-alkylated dipeptides and of their esters |
| 03/27/1985 | EP0135171A2 Pharmaceutical composition for interferon application |
| 03/27/1985 | EP0135159A2 Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same |
| 03/27/1985 | EP0135108A2 Nucleotide hybridization assay for protozoan parasites |
| 03/27/1985 | EP0135094A1 Microbial expression of insulin-like growth factor |
| 03/27/1985 | EP0135073A2 Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
| 03/27/1985 | EP0134923A2 Process for preparing a human endogenous cancer regulatory factor, pharmaceutical composition containing the same, and human monocytic leukemia cell lines |
| 03/27/1985 | EP0134803A1 Monoclonal antibody |
| 03/26/1985 | US4507389 Determination of collagenase by reacting with peptide substrates |
| 03/26/1985 | US4507283 Streptokinase-human plasminogen activator complex blocked by a 2- or 4-aminobenzoyl group; anticoagulant |
| 03/26/1985 | US4507277 Composition and method for stimulating the synthesis of the melanotic pigment of the skin |
| 03/26/1985 | US4507235 Method for preparing peptides and intermediate products |
| 03/26/1985 | US4507233 Chromatography, proteins |
| 03/26/1985 | US4507230 Peptide synthesis reagents and method of use |
| 03/26/1985 | US4507229 Tissue protein PP4, a process for isolating it and its use |
| 03/20/1985 | EP0134773A1 Yeast copper-metallothionein gene |
| 03/20/1985 | EP0134729A1 Process for the preparation of globin from hemoglobin, and globin obtained in this process |
| 03/20/1985 | EP0134673A1 Improved plasmid vector and use thereof |
| 03/20/1985 | EP0134662A1 Production of bovine calf chymosin |
| 03/20/1985 | EP0134631A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
| 03/20/1985 | EP0134582A2 Novel peptides and process for preparing the same and pharmaceutical composition |
| 03/20/1985 | EP0134552A2 Monoclonal antibody with a high affinity for digoxin |
| 03/20/1985 | EP0134479A1 Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 03/20/1985 | EP0134385A2 A protein having cell growth stimulating action, composition thereof and method for producing the same |
| 03/20/1985 | EP0134320A1 Conjugates of proteins with anti-tumour agents |
| 03/20/1985 | EP0134247A1 Protein with oncostatic effect, process for its preparation, and oncostatic drug containing it |
| 03/19/1985 | US4505897 Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith |
| 03/19/1985 | US4505853 Enzyme-resistant immunomodulatory peptides |
| 03/19/1985 | US4505822 Process for separating substances from one another using a fibrin gel filter |
| 03/19/1985 | US4505817 Fibrin gel-containing filter of porous material |
| 03/14/1985 | WO1985001067A1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 03/14/1985 | WO1985001066A1 Process for producing peptide |
| 03/14/1985 | WO1985000977A1 Vaccine and antigen against paludism and preparation process thereof |
| 03/14/1985 | WO1985000976A1 Method and materials for development of immunological responses protective against malarial infection |
| 03/14/1985 | WO1985000975A1 Method and materials for development of immunological responses protective against malarial infection |
| 03/14/1985 | WO1985000974A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 03/13/1985 | EP0134085A1 DNA encoding a GRF precursor |
| 03/13/1985 | EP0134070A2 Improved cyanogen bromide cleavage of peptides |
| 03/13/1985 | EP0134041A1 N-Chlorocarbonyloxy-5-norbornene-2,3-dicarboximide, process for its preparation and its use |
| 03/12/1985 | US4504644 Sunscreen agents |
| 03/12/1985 | US4504586 Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1 |
| 03/12/1985 | US4504467 Antibiotics, oxidative deamination, feeds |
| 03/12/1985 | US4504415 Synthesis of thymosin α1 and desacetyl thymosin α1 |
| 03/06/1985 | EP0133833A1 Compositions of vaccines conditioned for the vaccination of immunitarily non-naive subjects against a predetermined pathogenic agent and containing a haptene itself comprising an antigenic site characteristic of said pathogenic agent or an oligomer of this haptene |
| 03/06/1985 | EP0133756A2 Vector for expression of polypeptides |
| 03/05/1985 | US4503039 Coagulant plasma-protein solution |
| 03/05/1985 | US4503038 Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid |
| 03/05/1985 | US4503035 Human leukocyte interferon |
| 03/05/1985 | CA1183526A1 Oligopeptides with specific inhibiting properties of collagen induced aggregation, process for preparing the same and pharmaceutical compositions containing them |
| 03/05/1985 | CA1183525A1 Phosphorylmuramyl peptides and processes for the manufacture thereof |
| 03/05/1985 | CA1183470A1 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
| 03/05/1985 | CA1183469A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells, antibody, and method |
| 03/05/1985 | CA1183451A1 Method for producing a csap tryptic peptide and anti- csap antibodies |
| 02/28/1985 | WO1985000832A1 Production of streptococal m protein immunogens and molecular probes |
| 02/28/1985 | WO1985000831A1 Microbial expression of insulin-like growth factor |
| 02/28/1985 | WO1985000830A1 Process for producing human interleukine 1 and related drugs |
| 02/28/1985 | WO1985000829A1 Dna plasmids |
| 02/28/1985 | WO1985000817A1 Microbial expression of interleukin ii |
| 02/28/1985 | WO1985000812A1 Conjugates of proteins with anti-tumour agents |
| 02/28/1985 | WO1985000809A1 The synthesis of cyclopropane amino acids and peptides |
| 02/28/1985 | WO1985000807A1 Polypeptide-induced monoclonal antibodies to oncoproteins |
| 02/28/1985 | WO1985000750A1 Hybridoma cell line producing suppressive factor of allergy |
| 02/28/1985 | EP0107710A4 The manufacture and expression of genes for calcitonin and polypeptide analogs thereof. |
| 02/27/1985 | EP0133599A2 Vaccines and compositions against hepatitis B viral infections |
| 02/27/1985 | EP0133553A2 Reagent and process for the quantitative determination of antibodies |
| 02/27/1985 | EP0133551A2 Monoclonal antibody which recognizes a structure which is common to the human interleukin-2 (TCGF) and to the light chain lambda of human immunoglobulin, and hybridoma cell lines producing this monoclonal antibody |
| 02/26/1985 | US4501694 Phosphorylated soybean protein |
| 02/26/1985 | US4501693 Hydrolyzing proteoglycans with lysozyme |
| 02/26/1985 | CA1183130A1 L-argininal derivatives and a method of manufacturing the same |
| 02/26/1985 | CA1183129A1 Lipophilic muramyl peptides and processes for their manufacture |
| 02/20/1985 | EP0133403A2 Nucleotide sequence coding for the signal peptide of diphteria toxin, vector containing this nucleotide sequence, its use in the transformation of microorganisms and peptide compositions obtained therefrom. |
| 02/20/1985 | EP0133358A2 Processes for the production of agents for inhibiting the proliferation of malignant tumour cells, and agents produced thereby |
| 02/20/1985 | EP0133308A2 Agent for controlling the appetite and process for its preparation |
| 02/20/1985 | EP0133285A1 Crystal suspensions of insulin derivatives, process for their preparation and their use |
| 02/20/1985 | EP0133284A2 Process for isolating and purifying interferon |
| 02/20/1985 | EP0133282A1 Preparation of acidamide-carboxy-terminal polypeptides |
| 02/20/1985 | EP0051071B1 Tryptophane derivative and process for preparing same |
| 02/19/1985 | US4500713 Therapeutic dipeptides |
| 02/19/1985 | US4500518 Amino thiol dipeptides |
| 02/19/1985 | US4500467 Benzoylthio compounds, their preparation and their use as drugs |
| 02/19/1985 | US4500451 New protein PP13 extracted from human placental tissues and use thereof |
| 02/19/1985 | US4500450 Polypeptide having an action on the immunological system, process for its isolation and purification, its use, agents containing this compound, and its cleavage products, their use and agents containing these products |
| 02/19/1985 | CA1182811A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications |
| 02/19/1985 | CA1182748A1 Method for synthesizing procoagulant factor viii activity |
| 02/14/1985 | WO1985000606A1 Human il-2 and process for its preparation |
| 02/14/1985 | WO1985000597A1 Insulin-potentiating peptides |
| 02/13/1985 | EP0133123A1 Immunogens of papilloma viruses |
| 02/13/1985 | EP0133063A1 Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2 |
| 02/13/1985 | EP0133029A2 A process for producing inhibiting agents against proliferation of malignant tumour cells, and agents produced thereby |
| 02/13/1985 | EP0132979A2 Aqueous atelocollagen solution and method of preparing same |
| 02/13/1985 | EP0132919A1 Peptides |
| 02/13/1985 | EP0132770A1 Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus |
| 02/13/1985 | EP0132769A1 Pharmaceutical formulation for the treatment of diabetes mellitus |